Skip to main content
. 2020 Nov 24;15:3051–3061. doi: 10.2147/COPD.S283020

Table 2.

Primary Endpoint and Secondary Endpoints in the Two Groups

Outcome All Patients (n=320) HFNC Group (n=160) COT Group (n=160) P
Primary end point
 Treatment failure, need of NIV, no. (%) 47(14.7) 16(10.0) 31(19.4) 0.026
Secondary end point
 Patients received NIV, no. (%) 39(12.2) 13(8.1) 26(16.3) 0.039
 CAT scores at discharge 15.2±7.8 12.0±7.6 17.0±7.3 0.002
 Subjective discomfort score 3.3±1.6 2.3±1.1 3.9±1.6 <0.001
 Hospital lengths of stay (days) 12.7±4.8 12.2±5.3 12.9±4.5 0.453
 Readmission rate within 3 months, no. (%) 77 (24.1) 32 (20.0) 45 (28.1) 0.116
Reason for NIV
 Respiratory acidosis 36(11.3) 12(7.5) 24(15.0) 0.050
 Obvious dyspnea 11(3.4) 4(2.5) 7(4.4) 0.542

Notes: Data are presented as mean ± standard deviation or No. (%). Treatment failure was defined as worsening of the patients’ condition to the point that noninvasive or invasive mechanical ventilation was required.

Abbreviations: CAT score, COPD assessment test score; COT, conventional oxygen therapy; HFNC, high-flow nasal cannula oxygen therapy; NIV, noninvasive mechanical ventilation.